Literature DB >> 7644401

Abdominal pain: do not forget Thorotrast!

E Weber1, F Laarbaui, L Michel, J Donckier.   

Abstract

The use of Thorotrast (25% thorium dioxide), a radiologic contrast agent used up until the mid-1950s, was associated with a wide range of malignancies, mainly of hepatic origin. We report a case of Thorotrast-induced hepatocarcinoma in an 82-year-old woman.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7644401      PMCID: PMC2398137          DOI: 10.1136/pgmj.71.836.367

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

1.  The excretion of thorium and thorium daughters after thorotrast administration.

Authors:  J B HURSH; L T STEADMAN; W B LOONEY; M COLODZIN
Journal:  Acta radiol       Date:  1957-06       Impact factor: 1.990

2.  Thorium dioxide, forgotten but not gone.

Authors:  D Kessel; K F Robbins; M L Wilkinson; P M Smith
Journal:  Br J Radiol       Date:  1991-11       Impact factor: 3.039

3.  Late effects of thorium dioxide on the liver of patients in Sweden.

Authors:  S Dahlgren
Journal:  Ann N Y Acad Sci       Date:  1967-12-11       Impact factor: 5.691

4.  Multiple malignant neoplasms 40 years after angiography with Thorotrast.

Authors:  P Silpananta; F F Illescas; H Sheldon
Journal:  Can Med Assoc J       Date:  1983-02-01       Impact factor: 8.262

5.  Alteration of the c-fms gene in a blood sample from a Thorotrast individual.

Authors:  F R Collart; M Horio; R A Schlenker; R L Kathren; E Huberman
Journal:  Health Phys       Date:  1992-07       Impact factor: 1.316

Review 6.  Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma.

Authors:  Y Ito; M Kojiro; T Nakashima; T Mori
Journal:  Cancer       Date:  1988-09-15       Impact factor: 6.860

  6 in total
  1 in total

1.  History note: tragedy of Thorotrast.

Authors:  Shoichi Takekawa; Yoshihiko Ueda; Yoshihiro Hiramatsu; Kihachiro Komiyama; Hirotsugu Munechika
Journal:  Jpn J Radiol       Date:  2015-09-29       Impact factor: 2.374

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.